Lung Cancers Active Not Recruiting Phase 1 / 2 Trials for Erlotinib (DB00530)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

DBCOND0072929 (Lung Cancers)Active Not Recruiting1 / 2 IdentifierTitlePurposeDrugs
NCT01455389TUSC2-nanoparticles and Erlotinib in Stage IV Lung CancerTreatment
NCT00408499Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung CancerTreatment